Two not-for-profit organizations are teaming up to promote common data standards for clinical trials on major diseases as a way to spur more effective research into therapies using larger pools of patient information.
Not-for-profit groups team to promote data standards, info sharing
The Tucson, Ariz.-based Critical Path Institute, under the direction of President and CEO Dr. Raymond Woosley, has established a formal partnership with the Clinical Data Interchange Standards Consortium, Austin, Texas, to allow the groups to coordinate data-sharing among drug researchers and pharmaceutical companies engaged in clinical trials.
The goal is to "address process gaps responsible for delays and inefficiencies in medical product development" for new therapies involving Huntington's disease, ALS, multiple sclerosis, lung cancer and diabetes, among other conditions identified as high-priority challenges by the Food and Drug Administration, according to a joint news release from the organizations. Critical Path previously worked on a similar project for Alzheimer's disease.
The news release quoted HHS Secretary Kathleen Sebelius as praising the groups' efforts to develop "common language and tools that facilitate communication and learning" among scientists around the world.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.